Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
The American Journal of Pathology|September 1, 1993
A putative marker for human melanoma. A monoclonal antibody derived from the melanoma gene in the Xiphophorus melanoma modelJ R Vielkind, V A Tron, B M Schmidt, et al.The British Journal of Dermatology|June 16, 2006
Update on the use of ciclosporin in immune-mediated dermatosesC E M Griffiths, A Katsambas, B A C Dijkmans, et al.The Journal of Investigative Dermatology|May 1, 1993
Leukemic T cells from patients with cutaneous T-cell lymphoma demonstrate enhanced activation through CDw60, CD2, and CD28 relative to activation through the T-cell antigen receptor complexE R Hansen, G L Vejlsgaard, K D Cooper, et al.Journal of the American Academy of Dermatology|January 1, 1990
Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic studyV C Ho, C E Griffiths, C N Ellis, et al.Archives of Dermatology|March 1, 1990
Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysisA K Gupta, C N Ellis, B J Nickoloff, et al.The British Journal of Dermatology|September 1, 1999
Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study GroupV C Ho, C E Griffiths, G Albrecht, et al.Journal of the American Academy of Dermatology|February 1, 1990
Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysisA K Gupta, C N Ellis, K D Cooper, et al.The British Journal of Dermatology|June 14, 2005
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trialA B Gottlieb, C E M Griffiths, V C Ho, et al.The British Journal of Dermatology|April 30, 2004
Ciclosporin in psoriasis clinical practice: an international consensus statementC E M Griffiths, L Dubertret, C N Ellis, et al.Pageof 7